Heron Therapeutics
HRTX
#8256
Rank
A$0.36 B
Marketcap
A$1.97
Share price
0.00%
Change (1 day)
-22.07%
Change (1 year)

Heron Therapeutics (HRTX) - Total assets

Total assets on the balance sheet as of September 2025 : A$0.37 Billion

According to Heron Therapeutics's latest financial reports the company's total assets are A$0.37 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Heron Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$0.37 B14.77%
2023-12-31A$0.32 B-11.44%
2022-12-31A$0.36 B-12.55%
2021-12-31A$0.42 B-8.29%
2020-12-31A$0.45 B-37.22%
2019-12-31A$0.73 B11.64%
2018-12-31A$0.65 B118.6%
2017-12-31A$0.30 B220.58%
2016-12-31A$93.61 M-50.52%
2015-12-31A$0.18 B101.95%
2014-12-31A$93.69 M10.06%
2013-12-31A$85.13 M58.06%
2012-12-31A$53.86 M184.01%
2011-12-31A$18.96 M561.75%
2010-12-31A$2.86 M-71.24%
2009-12-31A$9.96 M-40.42%
2008-12-31A$16.72 M-60.43%
2007-12-31A$42.26 M93.13%
2006-12-31A$21.88 M78.53%
2005-12-31A$12.25 M-44.25%
2004-12-31A$21.98 M24.23%
2003-12-31A$17.69 M-43.92%
2002-12-31A$31.56 M-31.48%
2001-12-31A$46.05 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Alkermes
ALKS
A$3.50 B 835.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
A$1.95 B 421.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$0.45 B 21.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$2.22 B 493.20%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
A$0.25 B-31.78%๐Ÿ‡บ๐Ÿ‡ธ USA